Trailing-twelve-month (TTM) revenue is $422.65 Million with a year-over-year growth of +7.76%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $104,508,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $106,135,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $103,169,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $108,837,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $422,649,000 |
Current P/S: $1,385,832,186 market capitalization ÷ $422,649,000 TTM revenue = 3.28x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:05:04.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $108.84M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:06:18.303Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| Corporate Segment | $0 |
$422.65M
$422.65 Million
+7.76%
vs. $392.21M a year ago (TTM)
+12.35%
5 Year compound annual growth rate
1 Year
+7.76%
3 Year
+13.17%
5 Year
+12.35%
10 Year
+8.01%
15 Year
+5.11%
20 Year
+3.57%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $409.34M | +$33.33M | +8.86% |
| 2024 | $376.01M | +$49.70M | +15.23% |
| 2023 | $326.31M | +$70.65M | +27.63% |
| 2022 | $255.66M | +$17.03M | +7.13% |
| 2021 | $238.63M | +$7.63M | +3.30% |
| 2020 |
TTM Growth
+7.76%
3-Year CAGR
+13.17%
5-Year CAGR
+12.35%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $231.00M |
| ($4.58M) |
| (1.94%) |
| 2019 | $235.58M | +$12.18M | +5.45% |
| 2018 | $223.40M | +$19.20M | +9.40% |
| 2017 | $204.20M | +$9.19M | +4.71% |
| 2016 | $195.02M | +$4.19M | +2.19% |
